MINI FUTURE SHORT - MEDTRONIC Stock

Certificat

DE000PD5W0B3

Delayed Deutsche Boerse AG 06:50:33 2024-06-20 am EDT
2.7 EUR +0.37% Intraday chart for MINI FUTURE SHORT - MEDTRONIC
Current month+5.91%
1 month+29.95%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-20 2.7 +0.37%
24-06-19 2.69 +0.75%
24-06-18 2.67 -0.37%
24-06-17 2.68 +3.47%
24-06-14 2.59 +3.60%

Delayed Quote Deutsche Boerse AG

Last update June 20, 2024 at 06:50 am EDT

More quotes

Static data

Product typeKnock-Out mit Stop Loss
Buy / SellPUT
Underlying MEDTRONIC PLC
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PD5W0B
ISINDE000PD5W0B3
Date issued 2022-05-12
Strike 108.5 $
Maturity Unlimited
Parity 10 : 1
Emission price 1.24
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 3.77
Lowest since issue 0.63
Spread 0.1
Spread %3.57%

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
79.75 USD
Average target price
94.07 USD
Spread / Average Target
+17.95%
Consensus